Insurance coverage for post-stroke cell therapy is virtually non-existent globally. US Medicare and commercial insurance do not reimburse. European insurance schemes (Spain, Portugal, occasionally Germany) selectively cover for severe, chronic stroke disability refractory to conventional rehabilitation when the patient meets strict medical necessity criteria. Out-of-pocket payment is standard; most families self-fund or enrol in sponsored trials.
Stroke recovery cell therapy ranges from €6,000–8,500 per protocol in specialised neurorehabilitation centres. Intravenous MSC infusion (€6,000–7,000) is most accessible. Intra-arterial delivery via neuroradiology (€7,500–8,500) reaches lesions more directly but requires specialist infrastructure. Neurogenic cell infusions are priced similarly (€6,500–8,000). Most protocols involve 1–2 infusions over 3–6 months, though multi-dose regimens are emerging. Insurance coverage is extremely rare globally; only a few European countries (Spain, Portugal) occasionally reimburse under compassionate frameworks for severe, chronic disability.
Съм ли кандидат? → · Stroke Recovery: full overview → · Цена Възстановяване след инсулт → · Cost →
Медицински преглед от редакционния екип на StemCellAtlas с Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.
GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.
Безплатна медицинска оценка